{"product_id":"the-new-prescriber-isbn-9781119833154","title":"The New Prescriber","description":"\u003cp\u003e\u003cb\u003eTake an evidence-based approach to prescribing decisions with this comprehensive guide\u003c\/b\u003e \u003c\/p\u003e\u003cp\u003ePrescribing decisions are among the most important parts of clinical practice. Balancing patient needs, possible drug interactions, the probability of adverse drug reactions, and more requires an evidence-based approach rooted in pharmacological principles. \u003ci\u003eThe New Prescriber: An Integrated Approach to Medical and Non-medical Prescribing \u003c\/i\u003eoffers a thorough, accessible introduction to the core components of prescribing, essential for any student preparing for clinical practice. Now fully updated to reflect the latest best practices and to address questions raised by different prescribing settings, it promises to continue as the key introduction to this vital subject. \u003c\/p\u003e\u003cp\u003eReaders of the second edition of \u003ci\u003eThe New Prescriber \u003c\/i\u003ewill also find: \u003c\/p\u003e\u003cul\u003e\n\u003cli\u003eAn introduction to the principles of pharmacodynamics and pharmacokinetics\u003c\/li\u003e\n\u003cli\u003eNew sections covering topics including illegal and illicit drugs, overdose and deprescribing, and more\u003c\/li\u003e\n\u003cli\u003eA thorough glossary with key terms\u003c\/li\u003e\n\u003c\/ul\u003e \u003cp\u003e\u003ci\u003eThe New Prescriber\u003c\/i\u003e is ideal for all non-medical prescribing students, nursing, allied health professionals, and medical students. \u003c\/p\u003e\u003cp\u003eList of Contributors xxvi\u003c\/p\u003e \u003cp\u003eForeword xxvii\u003c\/p\u003e \u003cp\u003ePreface xxviii\u003c\/p\u003e \u003cp\u003eAcknowledgements xxix\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 1 The Patient 1\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eSection Introduction 1\u003c\/p\u003e \u003cp\u003e1 The Consultation 3\u003cbr\u003e \u003ci\u003eFrank Coffey and Dianne Bowskill\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e2 Accountability and Prescribing 14\u003cbr\u003e \u003ci\u003eMatthew Boyd, Stephanie Bridges, and Helen Boardman\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e3 Prescribing and the Law 23\u003cbr\u003e \u003ci\u003eRichard Griffith\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e4 The Ethics of Prescribing 36\u003cbr\u003e \u003ci\u003eMatthew Boyd, Stephanie Bridges, and Helen Boardman\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e5 Prescribing in Practice 44\u003cbr\u003e \u003ci\u003eDianne Bowskill and Daniel Shipley\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e6 Public Health Issues 53\u003cbr\u003e \u003ci\u003eMichael Watson and Katharine Whittingham\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 2 Pharmacology 63\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eSection Introduction 65\u003c\/p\u003e \u003cp\u003e7 General Principles of Pharmacology 67\u003cbr\u003e \u003ci\u003eJoanne Lymn and Alison Mostyn\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e8 Pharmacokinetics 1: Absorption and Distribution 79\u003cbr\u003e \u003ci\u003eJoanne Lymn and Alison Mostyn\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e9 Pharmacokinetics 2: Metabolism and Excretion 92\u003cbr\u003e \u003ci\u003eJoanne Lymn and Alison Mostyn\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e10 Routes of Administration 106\u003cbr\u003e \u003ci\u003eJoanne Lymn and Roger Knaggs\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e11 Variations in Drug Handling 114\u003cbr\u003e \u003ci\u003eMichael Randall\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e12 Polypharmacy and Medicines Optimisation 124\u003cbr\u003e \u003ci\u003eDaniel Shipley\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e13 Adverse Drug Reactions and Interactions 134\u003cbr\u003e \u003ci\u003eAlison Mostyn and Daniel Shipley\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e14 Introduction to the Autonomic Nervous System 144\u003cbr\u003e \u003ci\u003eJoanne Lymn\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e15 Clinical Application of the Principles of the Autonomic Nervous Systems 157\u003cbr\u003e \u003ci\u003eJoanne Lymn\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e16 The Gastrointestinal System 167\u003cbr\u003e \u003ci\u003eMichael Randall\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e17 Cardiovascular Drugs and Diseases 177\u003cbr\u003e \u003ci\u003eRichard Roberts\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e18 Haemostasis and Thrombosis 196\u003cbr\u003e \u003ci\u003eMichael Randall\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e19 The Renal System 208\u003cbr\u003e \u003ci\u003eMichael Randall\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e20 The Respiratory System 221\u003cbr\u003e \u003ci\u003eRichard Roberts\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e21 Introduction to the Central Nervous System 235\u003cbr\u003e \u003ci\u003eYvonne Mbaki\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e22 Neurodegenerative Disorders 245\u003cbr\u003e \u003ci\u003eDavid Kendall\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e23 Depression and Anxiety 256\u003cbr\u003e \u003ci\u003eYvonne Mbaki\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e24 Schizophrenia 267\u003cbr\u003e \u003ci\u003eDavid Kendall\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e25 Epilepsy and Antiseizure Drugs 277\u003cbr\u003e \u003ci\u003eMichael F O’Donoghue and Christina Giavasi\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e26 Pain and Analgesia 293\u003cbr\u003e \u003ci\u003eRoger Knaggs\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e27 Drugs of Misuse 308\u003cbr\u003e \u003ci\u003eMichael Randall\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e28 Antibacterial Chemotherapy 315\u003cbr\u003e \u003ci\u003eTim Hills\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e29 Antibiotic Resistance and Clostridioides Difficile 331\u003cbr\u003e \u003ci\u003eTim Hills\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e30 Antifungal and Antiviral Drugs 342\u003cbr\u003e \u003ci\u003eTim Hills\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e31 The Endocrine System 352\u003cbr\u003e \u003ci\u003eAlison Mostyn and Daniel Shipley\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e32 Contraception and Reproductive Health 369\u003cbr\u003e \u003ci\u003eAlison Mostyn and Anna Soames\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e33 Cancer Pharmacotherapy 381\u003cbr\u003e \u003ci\u003eMichael Randall\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e34 Musculoskeletal Disease 392\u003cbr\u003e \u003ci\u003eSana Awan and David Andrew Walsh\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eGlossary 409\u003c\/p\u003e \u003cp\u003eActivity Answers 417\u003c\/p\u003e \u003cp\u003eIndex 445\u003c\/p\u003e  \u003cp\u003e\u003cb\u003eJoanne Lymn\u003c\/b\u003e is Professor of Healthcare Education at University of Nottingham, UK, and a National Teaching Fellow. \u003c\/p\u003e\u003cp\u003e\u003cb\u003eAlison Mostyn\u003c\/b\u003e is Professor of Pharmacology Education for Health and Director of Teaching and Learning, University of Nottingham, UK. \u003c\/p\u003e\u003cp\u003e\u003cb\u003eRoger Knaggs\u003c\/b\u003e is Professor of Pain Management at University of Nottingham, UK, and Specialist Pharmacist in Pain Management at Primary Integrated Community Services. He is also President of the British Pain Society. \u003c\/p\u003e\u003cp\u003e\u003cb\u003eMichael Randall\u003c\/b\u003e is Professor of Pharmacology at University of Nottingham, UK, and a Fellow of the British Pharmacological Society. \u003c\/p\u003e\u003cp\u003e\u003cb\u003eDianne Bowskill\u003c\/b\u003e is Associate Professor of Prescribing Education and Lead for Non-medical prescribing, University of Nottingham, UK.   \u003c\/p\u003e\u003cp\u003e\u003cb\u003eTake an evidence-based approach to prescribing decisions with this comprehensive guide\u003c\/b\u003e \u003c\/p\u003e\u003cp\u003ePrescribing decisions are among the most important parts of clinical practice. Balancing patient needs, possible drug interactions, the probability of adverse drug reactions, and more requires an evidence-based approach rooted in pharmacological principles. \u003ci\u003eThe New Prescriber: An Integrated Approach to Medical and Non-medical Prescribing \u003c\/i\u003eoffers a thorough, accessible introduction to the core components of prescribing, essential for any student preparing for clinical practice. Now fully updated to reflect the latest best practices and to address questions raised by different prescribing settings, it promises to continue as the key introduction to this vital subject. \u003c\/p\u003e\u003cp\u003eReaders of the second edition of \u003ci\u003eThe New Prescriber \u003c\/i\u003ewill also find: \u003c\/p\u003e\u003cul\u003e\n\u003cli\u003eAn introduction to the principles of pharmacodynamics and pharmacokinetics\u003c\/li\u003e\n\u003cli\u003eNew sections covering topics including illegal and illicit drugs, overdose and deprescribing, and more\u003c\/li\u003e\n\u003cli\u003eA thorough glossary with key terms\u003c\/li\u003e\n\u003c\/ul\u003e \u003cp\u003e\u003ci\u003eThe New Prescriber\u003c\/i\u003e is ideal for all non-medical prescribing students, nursing, allied health professionals, and medical students.\u003c\/p\u003e","brand":"Wiley-Blackwell","offers":[{"title":"Default Title","offer_id":47990298706149,"sku":"NP9781119833154","price":38.5,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1842\/7735\/files\/9781119833154.jpg?v=1761787255","url":"https:\/\/k12savings.com\/es\/products\/the-new-prescriber-isbn-9781119833154","provider":"K12savings","version":"1.0","type":"link"}